HB-adMSCS (Autologous)

autologous adipose-derived mesenchymal stem cells · Hope Biosciences Research Foundation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HB-adMSCS (Autologous), covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.